Review the side-effects of Ramelteon as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Denver, CO, June 20, 2005 – Ramelteon, a novel investigational compound under review with the FDA for the treatment of insomnia, reduced the time it took to fall asleep and increased total sleep time ...

Researchers found preliminary evidence for the effectiveness of ramelteon for the treatment of sleep disturbances after traumatic brain injury (TBI). Ramelteon is a melatonin-agonist without the risks ...

June 22, 2006 — Results from a 1-year open-label trial suggests that ramelteon is safe and effective for the long-term treatment of insomnia. The findings were presented Tuesday at the Associated ...

Nat Clin Pract Neurol. 2007;3(4):221-228. Another practical -- although somewhat banal -- advantage of ramelteon over melatonin is the fact that melatonin has not yet obtained regulatory approval to ...

Japan’s top drug maker, Takeda Pharmaceuticals, said yesterday it plans to be the sole marketer of its insomnia drug Ramelteon, marking the first time the company has sold a product in the U.S. on its ...

Atlanta, GA, May 23, 2005 – Results of a clinical study indicated that ramelteon, an investigational compound currently under review by the FDA for insomnia treatment, had no more potential for abuse ...

PO- The recommended dose is 8 mg taken within 30 minutes before going to bed. Difficulty in initiating and maintaining sleep is known as insomnia. It is a symptom that occurs due to other disorders ...

UCB says it is withdrawing an application to market Vimpat, as a treatment for diabetic neuropathic pain after receiving a negative response from advisors to the European Medicines Agency. UCB says it ...